Mera Pharmaceuticals, Inc. Share Price

Equities

MRPI

US58732R1032

Biotechnology & Medical Research

Market Closed - OTC Markets 16:38:58 05/04/2024 BST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Mera Pharmaceuticals, Inc. -.--% -.--%
Sales 2010 289K 23.07M Sales 2011 303K 24.17M Capitalization 1.1M 87.5M
Net income 2010 - 0 Net income 2011 - 0 EV / Sales 2010 5.85 x
Net Debt 2010 46K 3.67M Net Debt 2011 295K 23.55M EV / Sales 2011 4.59 x
P/E ratio 2010
-2.88 x
P/E ratio 2011
-4.98 x
Employees 4
Yield 2010 *
-
Yield 2011
-
Free-Float 99.91%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.03
5 years
0.00
Extreme 0
0.05
10 years
0.00
Extreme 0
0.05
More quotes
Managers TitleAgeSince
President 57 16/03/21
Members of the board TitleAgeSince
President 57 16/03/21
Director/Board Member 60 16/03/21
More insiders
Mera Pharmaceuticals, Inc. is a marine biotechnology company. The Company focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The Company manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available in three formulations, such as rejuvenating formula, sports formula and salmon essentials, such as natural astaxanthin combined with a blend of fish and salmon oil. The Company also produces sea salt products, such as gourmet salt and nigari. The gourmet salt includes Hawaiian Furikake, Hawaiian Furikake refillable grinder, Kona Sea Salt, Kona Sea Salt flake salt case, Kona Sea Salt grinder and Kona Sea Salt grinder case. The Company offers nigari in sizes ranging from one gallon to 250 gallons.
More about the company